Literature DB >> 29689270

Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.

Marta Panella1, Nicola Mosca1, Armando Di Palo1, Nicoletta Potenza1, Aniello Russo2.   

Abstract

MicroRNA-125a exhibits an antiproliferative activity and is downregulated in several types of tumors, including hepatocellular carcinoma where it targets sirtuin-7, matrix metalloproteinase-11, and c-Raf. Another target of miR-125a is Lin28, a pluripotency factor that is generally undetectable in differentiated cells but is often upregulated/reactivated in tumors where it acts as an oncogenic factor promoting cell proliferation and tumor progression. In this study we show that downregulation of Lin28b by miR-125a partially accounts for its antiproliferative activity toward hepatocellular carcinoma cells. We also found that Lin28b is able to bind a conserved GGAG motif of pre-miR-125a and to inhibit its maturation in hepatocellular carcinoma cells. Reciprocal inhibition between miR-125a and Lin28b reasonably generates a positive feedback loop where reactivation of Lin-28b inhibits the expression of both miR-125a and let-7, reinforcing its own expression and leading to a marked overexpression of the mitogenic targets of the two miRNAs. On the other hand, perturbation of these circuits by overexpression of miR-125a suppresses Lin28b leading to a decreased cell proliferation. Overall, these data support a tumor suppressive role for miR-125a and contribute to the elucidation of its molecular targets.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Cell proliferation; Hepatocarcinoma; RNA interference; microRNA

Mesh:

Substances:

Year:  2018        PMID: 29689270     DOI: 10.1016/j.bbrc.2018.04.167

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  miR-125b prevent the progression of esophageal squamous cell carcinoma through the p38-MAPK signaling pathway.

Authors:  Chun Cheng; Qinghua Mao; Minxin Shi; Haimin Lu; Biao Shen; Ting Xiao; Aimin Yang; Yupeng Liu
Journal:  J Gastrointest Oncol       Date:  2020-12

2.  Lin28b is involved in curcumin-reversed paclitaxel chemoresistance and associated with poor prognosis in hepatocellular carcinoma.

Authors:  Nan Tian; Wenbing Shangguan; Zuolin Zhou; Yao Yao; Chunlei Fan; Lijun Cai
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

3.  Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.

Authors:  Min Wang; Shan Huang; Zefeng Chen; Zhiwei Han; Kezhi Li; Chuang Chen; Guobin Wu; Yinnong Zhao
Journal:  BMC Cancer       Date:  2020-11-23       Impact factor: 4.430

4.  A Novel ceRNA Regulatory Network Involving the Long Non-Coding Antisense RNA SPACA6P-AS, miR-125a and its mRNA Targets in Hepatocarcinoma Cells.

Authors:  Armando Di Palo; Chiara Siniscalchi; Nicola Mosca; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

5.  miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ.

Authors:  Meiyuan Yang; Xiaoli Tang; Zheng Wang; Xiaoqing Wu; Dong Tang; Daorong Wang
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.